157 related articles for article (PubMed ID: 3404766)
1. Actions of a newly synthesized compound (711389-S) on various types of experimentally induced arrhythmias in mammalian species in situ.
Kadowaki Y; Ohta T; Hotokebuchi N; Kimoto S; Haruna M; Nakao T; Ueda M; Nishi K
Jpn J Pharmacol; 1988 Apr; 46(4):359-72. PubMed ID: 3404766
[TBL] [Abstract][Full Text] [Related]
2. [Effects of lorcainide, a new antiarrhythmic agent, on experimental cardiac arrhythmias].
Fukuda H; Goto M; Kondo M; Uchigasaki T; Sekino Y
Nihon Yakurigaku Zasshi; 1983 Feb; 81(2):115-26. PubMed ID: 6852683
[TBL] [Abstract][Full Text] [Related]
3. Antiarrhythmic activity of dextro- and levo-isomers of 5-methyl-8-(2-hydroxy-3-t-butylamino-propoxy) coumarin hydrocholoride (bucumolol), a beta-adrenergic blocking agent, on aconitine-induced atrial and ouabain-induced ventricular arrhythmias in dogs.
Nakayama K; Oshima T; Koike H
Jpn J Pharmacol; 1979 Dec; 29(6):935-45. PubMed ID: 44326
[TBL] [Abstract][Full Text] [Related]
4. Antiarrhythmic effect of a new class 1 antiarrhythmic drug, nicainoprol, on canine ventricular arrhythmias.
Hashimoto K; Akiyama K; Mitsuhashi H
Jpn J Pharmacol; 1989 Feb; 49(2):245-54. PubMed ID: 2733262
[TBL] [Abstract][Full Text] [Related]
5. Effects of AH-1058, a new antiarrhythmic drug, on experimental arrhythmias and cardiac membrane currents.
Takahara A; Uneyama H; Sasaki N; Ueda H; Dohmoto H; Shoji M; Hara Y; Nakaya H; Yoshimoto R
J Cardiovasc Pharmacol; 1999 Apr; 33(4):625-32. PubMed ID: 10218734
[TBL] [Abstract][Full Text] [Related]
6. Antiarrhythmic effects of a novel diamine derivative, AN-132, on several animal models of cardiac arrhythmias.
Sakai K; Yamazaki T; Takagi M
Tohoku J Exp Med; 1987 Apr; 151(4):443-51. PubMed ID: 3617055
[TBL] [Abstract][Full Text] [Related]
7. Antiarrhythmic effect of the selective I1-imidazoline receptor modulator moxonidine on ouabain-induced cardiac arrhythmia in guinea pigs.
Mest HJ; Thomsen P; Raap A
Ann N Y Acad Sci; 1995 Jul; 763():620-33. PubMed ID: 7677382
[TBL] [Abstract][Full Text] [Related]
8. Antiarrhythmic and hemodynamic effects of prifuroline.
Benharkate M; Plassard G; Legeai J; Worcel M
Arzneimittelforschung; 1986 Dec; 36(12):1761-7. PubMed ID: 3566836
[TBL] [Abstract][Full Text] [Related]
9. N-(2,6-Dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate (SUN 1165): a new potent and long-acting antiarrhythmic agent.
Aisaka K; Hidaka T; Inomata N; Hamasaki S; Ishihara T; Morita M
Arzneimittelforschung; 1985; 35(8):1239-45. PubMed ID: 4074441
[TBL] [Abstract][Full Text] [Related]
10. Antiarrhythmic plasma concentrations of NIK-244 on canine ventricular arrhythmias.
Hashimoto K; Matsuzaki T; Haruno A
J Cardiovasc Pharmacol; 1989 Dec; 14(6):892-8. PubMed ID: 2481779
[TBL] [Abstract][Full Text] [Related]
11. Antiarrhythmic profile of a new class 1 drug, AHR 10718, on canine atrial and ventricular arrhythmia models.
Mitsuhashi H; Hashimoto K
Jpn J Pharmacol; 1988 Apr; 46(4):349-58. PubMed ID: 3404765
[TBL] [Abstract][Full Text] [Related]
12. Antiarrhythmic, hemodynamic and cardiac electrophysiological evaluation of N-(2,6-dimethylphenyl)-N'-[3-(1-methylethylamino)propyl]urea (Wy-42,362).
Bergey JL; Sulkowski T; Much DR; Wendt RL
Arzneimittelforschung; 1983; 33(9):1258-68. PubMed ID: 6685506
[TBL] [Abstract][Full Text] [Related]
13. [Experimental anti-arrhythmic effects of a new beta-adrenergic receptor blocking agent, dl-l-(tert. butylamino)-3-[(2-propinyloxy)phenoxy]2-propanol hydrochloride (dl Kö 1400-Cl)].
Matsubara I; Hashimoto K; Katano Y; Tsukada T; Matsuda H
Nihon Yakurigaku Zasshi; 1976 Jul; 72(5):557-71. PubMed ID: 11153
[TBL] [Abstract][Full Text] [Related]
14. Antiarrhythmic effects of bisaramil on triggered arrhythmias produced by intracoronary injection of digitalis and adrenaline in the dog.
Haruno A; Hashimoto K
Jpn J Pharmacol; 1995 May; 68(1):95-102. PubMed ID: 7494388
[TBL] [Abstract][Full Text] [Related]
15. Antiarrhythmic properties of 5-(3-tert-butylamino-2-hydroxy)propoxy-3,4-dihydrocarbostyril hydrochloride (OPC-1085), a newly synthesized, potent beta-adrenoreceptor antagonist.
Yabuuchi Y; Hashimoto K; Yamashita S; Uno T; Shintani S; Nakagiri N
Clin Exp Pharmacol Physiol; 1977; 4(6):545-59. PubMed ID: 22416
[TBL] [Abstract][Full Text] [Related]
16. The effects of bisaramil on experimental arrhythmias.
Paróczai M; Kárpáti E; Solti F
Pharmacol Res; 1990; 22(4):463-80. PubMed ID: 2402479
[TBL] [Abstract][Full Text] [Related]
17. Antiarrhythmic effects of an aconitine-like compound, TJN-505, on canine arrhythmia models.
Arita J; Xue YX; Aye NN; Fukuyama K; Wakui Y; Niitsu K; Maruno M; Siying C; Hashimoto K
Eur J Pharmacol; 1996 Dec; 318(2-3):333-40. PubMed ID: 9016923
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological investigation of a new anti-arrhythmic agent, GYKI-23 107.
Varró A; Rabloczky G; Jaszlits L; Kürthy M; Zubovics Z; Toldy L
Drugs Exp Clin Res; 1987; 13(1):21-8. PubMed ID: 3595441
[TBL] [Abstract][Full Text] [Related]
19. The antiarrhythmic and cardiovascular properties of 1-dimethyl isopropylamino-3-(2-phenylphenoxy)-propan-2-ol chloride, UM-424.
Kniffen FJ; Winokur S; Counsell RE; Lucchesi BR
J Pharmacol Exp Ther; 1976 Feb; 196(2):420-32. PubMed ID: 3643
[TBL] [Abstract][Full Text] [Related]
20. MS-551 and KCB-328, two class III drugs aggravated adrenaline-induced arrhythmias.
Xue Y; Yamada C; Aye NN; Hashimoto K
Br J Pharmacol; 1998 Aug; 124(8):1712-8. PubMed ID: 9756388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
